BioSpace News Archive

Drug Development

Boehringer Ingelheim and OSE Immunotherapeutics To Present Biomarker Analyses from the Phase 1 Clinical Trial with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors

OSE Immunotherapeutics, announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα inhibitor BI 765063 in patients with advanced solid tumors have been selected for presentation in an in-person poster session at the American Association Cancer for Research annual meeting to be held on April 8 – 13, 2022 in New Orleans, Louisiana.

March 9, 2022
·
6 min read
Spexis to Present Strategy Update and Full-Year 2021 Financial Results on March 24, 2022

Spexis AG announced that it will publish its full-year financial results for 2021 on March 24 at 7.30am CET.

March 9, 2022
·
2 min read
Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022

Transgene and BioInvent International AB jointly announce that an abstract reporting preclinical studies of BT-001, a novel oncolytic virus, has been selected for a poster presentation at the American Association for Cancer Research Annual Meeting 2022.

March 9, 2022
·
7 min read
Vicore strengthens rare lung disease pipeline with PAH indication

Vicore Pharma Holding AB, a clinical-stage pharmaceutical company developing medicines targeting the Angiotensin II type 2 receptor, announces plans to initiate a clinical trial with C21 in PAH.

March 9, 2022
·
4 min read
Business

Sectra’s nine-month interim report 2021/2022: The industry’s most satisfied customers for the ninth consecutive year

International medical imaging IT and cybersecurity company Sectra’s radiology module for enterprise imaging, Sectra PACS, received a top ranking in customer satisfaction surveys in the US, Canada and Asia/Oceania.

March 9, 2022
·
5 min read
Business

Mainz Biomed Announces Year End 2021 Results

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced key strategic and operational results for the year ended December 31, 2021.

March 9, 2022
·
10 min read
BioForest

Sirona Biochem Subsidiary, TFChem, Awarded Financing in Partnership with French Government

Sirona Biochem Corp. is pleased to announce that its wholly owned subsidiary TFChem, has been awarded financing to develop an advanced chemistry process that could improve the manufacturing of active ingredients.

March 9, 2022
·
3 min read
Drug Development

ITM Presents Design of Second Phase III Trial, COMPOSE, with Radiopharmaceutical ITM-11 for the Treatment of Neuroendocrine Tumors at Annual ENETS Conference 2022

ITM Isotope Technologies Munich SE announced the presentation of the design for its second phase III trial, COMPOSE at the 19th Annual European Neuroendocrine Tumor Society Conference being held in a hybrid format in Barcelona on March 10-11, 2022.

March 9, 2022
·
5 min read
Increased Sales of the Consumer Version of Dosell

iZafe Group hereby announces that the increased market investments have yielded good results.

March 9, 2022
·
2 min read
Pharm Country

BioXcel Therapeutics to Present at the Barclays Global Healthcare Conference

BioXcel Therapeutics, Inc. announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, will present at the upcoming Barclays Global Healthcare Conference on Tuesday, March 15 at 3:50 p.m. ET.

March 9, 2022
·
3 min read